DK236288A - Middel til fremme af dyrevaekst - Google Patents

Middel til fremme af dyrevaekst

Info

Publication number
DK236288A
DK236288A DK236288A DK236288A DK236288A DK 236288 A DK236288 A DK 236288A DK 236288 A DK236288 A DK 236288A DK 236288 A DK236288 A DK 236288A DK 236288 A DK236288 A DK 236288A
Authority
DK
Denmark
Prior art keywords
growth
animals
digesting enzymes
promoting agent
enzymes
Prior art date
Application number
DK236288A
Other languages
English (en)
Other versions
DK171626B1 (da
DK236288D0 (da
Inventor
Thomas Ko Sai Ying
Original Assignee
Thomas Ko Sai Ying
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK236288(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thomas Ko Sai Ying filed Critical Thomas Ko Sai Ying
Publication of DK236288A publication Critical patent/DK236288A/da
Publication of DK236288D0 publication Critical patent/DK236288D0/da
Application granted granted Critical
Publication of DK171626B1 publication Critical patent/DK171626B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
DK236288A 1986-08-28 1988-04-28 Vækstfremmende middel til dyr samt fremgangsmåde til fremstilling af og anvendelse af midlet til fremme af dyrevækst DK171626B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH771486 1986-08-28
AUPH771486 1986-08-28
AU8700269 1987-08-17
PCT/AU1987/000269 WO1988001512A1 (en) 1986-08-28 1987-08-17 Animal growth promotant

Publications (3)

Publication Number Publication Date
DK236288A true DK236288A (da) 1988-04-28
DK236288D0 DK236288D0 (da) 1988-04-28
DK171626B1 DK171626B1 (da) 1997-03-03

Family

ID=3771790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236288A DK171626B1 (da) 1986-08-28 1988-04-28 Vækstfremmende middel til dyr samt fremgangsmåde til fremstilling af og anvendelse af midlet til fremme af dyrevækst

Country Status (13)

Country Link
US (2) US5567423A (da)
EP (1) EP0319545B1 (da)
JP (1) JP2593501B2 (da)
KR (1) KR940000065B1 (da)
CN (1) CN87105846A (da)
AU (1) AU604052B2 (da)
CA (1) CA1322159C (da)
DE (1) DE3777658D1 (da)
DK (1) DK171626B1 (da)
ES (1) ES2004989A6 (da)
MY (1) MY101342A (da)
NZ (1) NZ221577A (da)
WO (1) WO1988001512A1 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3777658D1 (de) * 1986-08-28 1992-04-23 Enzacor Pty Ltd Tierwachstumserreger.
ATE106242T1 (de) * 1986-08-28 1994-06-15 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
DK0463061T3 (da) * 1989-03-17 1993-07-12 Pitman Moore Inc Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
DK0590060T3 (da) * 1991-06-21 1998-05-11 Univ Cincinnati Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling
JPH0785700B2 (ja) * 1992-03-10 1995-09-20 全国農業協同組合連合会 鶏用酸素固定化グリットおよび鶏用飼料の消化率向上方法
DK0671943T3 (da) * 1992-06-30 2000-03-27 Cortecs Uk Ltd Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré
DE19531173A1 (de) * 1995-08-24 1997-02-27 Boehringer Mannheim Gmbh Verfahren zum Stabilisieren des Gehalts glykierten Proteins einer Probe auf einem Matrixmaterial
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates
US6559158B1 (en) 1997-11-03 2003-05-06 Ur Labs, Inc. Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
US6274591B1 (en) 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
ES2331442T3 (es) 1998-03-23 2010-01-04 General Mills, Inc. Encapsulacion de componentes en productos comestibles.
PT1069832E (pt) 1999-02-10 2004-08-31 Basf Ag Alimentacao para animais de um valor nutritivo mais elevado metodo para a sua producao e a sua utilizacao de um composto de polietileno glicol
DE19929257A1 (de) 1999-06-25 2000-12-28 Basf Ag Polymerbeschichtete, granulierte enzymhaltige Futtermittelzusätze und Verfahren zu deren Herstellung
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20030022909A1 (en) * 2001-06-05 2003-01-30 University Of Chicago Use of methylnaltrexone to treat immune suppression
ES2187378B2 (es) * 2001-11-14 2004-06-01 Alberto Vaquero Hernandez Formulacion de un pienso para el control del perfil de acidos grasos de la carne de cerdo.
WO2003059087A1 (en) 2002-01-15 2003-07-24 Basf Ag Granulates containing feed-enzymes
EP1638607A1 (en) * 2003-04-08 2006-03-29 Progenics Pharmaceuticals, Inc. Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
MXPA05010819A (es) * 2003-04-08 2006-03-30 Progenics Pharm Inc Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
CA2811272C (en) * 2003-04-08 2016-12-20 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
US20040266727A1 (en) * 2003-06-25 2004-12-30 Brandon Steve F. Nutritional supplement having a unique soluble and insoluble fiber blend and method of making the same
EP1845989A1 (en) * 2005-01-20 2007-10-24 Progenics Pharmaceuticals, Inc. Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (es) 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
US20080194611A1 (en) * 2005-06-03 2008-08-14 Alverdy John C Modulation of Cell Barrier Dysfunction
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
US20070197895A1 (en) * 2006-02-17 2007-08-23 Sdgi Holdings, Inc. Surgical instrument to assess tissue characteristics
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
EP2565195B1 (en) 2007-03-29 2015-05-06 Wyeth LLC Peripheral opioid receptor and antagonists and uses thereof
PL2137191T3 (pl) 2007-03-29 2016-12-30 Antagoniści obwodowego receptora opioidowego i ich zastosowania
AU2008349873B2 (en) 2008-02-06 2014-02-13 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2719134C (en) 2008-03-21 2015-06-30 The University Of Chicago Treatment with opioid antagonists and mtor inhibitors
CA2729582C (en) 2008-07-01 2017-09-19 University Of Chicago Particles containing an opioid receptor antagonist and methods of use
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
IN2012DN06642A (da) * 2010-01-15 2015-10-23 Kemin Ind Inc
GB201311272D0 (en) 2013-06-25 2013-08-14 Ucl Business Plc Anti-microbial agents and uses thereof
CN103461225B (zh) * 2013-07-30 2015-12-23 仙桃市强农水产专业合作社 黄鳝网箱人工仿生态苗种繁育方法
CN105592711A (zh) * 2013-07-30 2016-05-18 拜内梅尔克公司 用于泌乳反刍动物的饲料
JP6686013B2 (ja) 2014-10-17 2020-04-22 サリックス ファーマスーティカルズ，インコーポレーテッド 腫瘍の進行を減弱させるためのメチルナルトレキソンの使用
CN109475148A (zh) 2016-04-25 2019-03-15 Can 科技公司 可溶解的微量成分容器和使用此类容器制备动物饲料的方法
CN112425538B (zh) * 2020-11-20 2021-12-10 中国科学院南海海洋研究所 一种通过添加纤维素酶来提高小疣刺参幼体成活率和附着率的方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803304A (en) * 1965-07-19 1974-04-09 Armour Pharma Orally administratable pancreatic enzymes and methods of using same
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3789117A (en) * 1971-07-19 1974-01-29 Freunt Ind Co Ltd Process for the preparation of enteric medicaments
AU501555B2 (en) * 1975-01-14 1979-06-21 Richter, Esdene Fluid operated device
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
AU516072B2 (en) * 1975-06-10 1981-05-14 Johnson & Johnson Enteric coated digestive enzyme composition
JPS536483A (en) * 1976-07-02 1978-01-20 Tanabe Seiyaku Co Ltd Composition having enzymatic activity and its preparation
IT1115596B (it) * 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
NL7908326A (nl) * 1978-11-20 1980-05-22 Tno Geimmobiliseerd enzym, werkwijzen ter bereiding daarvan en een werkwijze voor het uitvoeren van een enzymatische reactie.
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
GB8326633D0 (en) * 1983-08-04 1983-11-09 Unilever Plc Compositions
DE3445301A1 (de) * 1984-12-12 1986-06-12 Hoechst Ag, 6230 Frankfurt Pankreasenzympraeparate und verfahren zu deren herstellung
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
DE3777658D1 (de) * 1986-08-28 1992-04-23 Enzacor Pty Ltd Tierwachstumserreger.

Also Published As

Publication number Publication date
US5567423A (en) 1996-10-22
KR940000065B1 (ko) 1994-01-05
AU7872187A (en) 1988-03-24
JP2593501B2 (ja) 1997-03-26
EP0319545B1 (en) 1992-03-18
EP0319545A1 (en) 1989-06-14
CN87105846A (zh) 1988-05-04
JPH01503707A (ja) 1989-12-14
DK171626B1 (da) 1997-03-03
MY101342A (en) 1991-09-05
AU604052B2 (en) 1990-12-06
NZ221577A (en) 1990-05-28
US5688502A (en) 1997-11-18
DK236288D0 (da) 1988-04-28
ES2004989A6 (es) 1989-02-16
WO1988001512A1 (en) 1988-03-10
CA1322159C (en) 1993-09-14
DE3777658D1 (de) 1992-04-23
KR880701559A (ko) 1988-11-03
EP0319545A4 (en) 1989-06-13

Similar Documents

Publication Publication Date Title
DK236288A (da) Middel til fremme af dyrevaekst
DK236388A (da) Mikrogranulaert praeparat, der er anvendeligt til frigoerelse af biologisk aktive materialer i tarmregionerne hos dyr
ATE87469T1 (de) Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
DE3783081D1 (de) Verfahren zur herstellung von bernsteinsaeure durch anaerobe fermentation.
Shibata et al. Hydrolysis and absorption of pantothenate and its coenzymes in the rat small intestine
DE69002604D1 (de) Pharmazeutische zubereitung mit verzoegerter freisetzung und seine herstellung.
DE3586346D1 (de) Mikrobielle herstellung von propionsaeure in mischkultur.
FI882707A0 (fi) Foerfarande och preparat foer hoejning av proteinhalten i mjoelk.
DE3864373D1 (de) Verfahren zur herstellung von bisphenolaromaten.
DE3789083D1 (de) Verfahren zur Herstellung von Polymaleinsäure.
ES8706831A1 (es) Un procedimiento para preparar un aminoacido opticamente activo
PT81372B (pt) Processo para a preparacao de glicopeptidos e de composicoes anti-bacterianas que os contem
EP0297397A3 (de) Herstellung von Diazo-und Azoverbindungen
DE58905691D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren.
PT87071A (pt) Calciumlactat-glycerin-addukt verfahren zu seiner herstellung sowie seine verwendung
DK183788D0 (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
ATE200687T1 (de) Verfahren zur herstellung von kationenaustaucher- membranen mit unlöslichen metallsalzen
JPS56109585A (en) Crosslinking of membrane containing microorganism
EA199800918A1 (ru) Происходящие от хозяина сигналы для индуцирования экспрессии гена изопреноида и их применение
SU1691866A1 (ru) Способ моделировани эмоционального стресса на животных
Sabatakou et al. Histochemical study of non-specific esterase activity in small and large intestine of young rabbit
JPS5581589A (en) Enzyme-containing film and method of making the same
JPS5799526A (en) Preparation of human adrenocorticotropic hormone
Visentin A biochemical and morphological analysis of the renal and hepatic peroxisomes of the frog, Rana pipiens
Wiersema Enzyme studies of commercial shrimp

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed